Interleukin-6 production in B-cell neoplasias and Castleman's disease: evidence for an additional paracrine loop (Q72130557)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8061104%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

title

Interleukin-6 production in B-cell neoplasias and Castleman's disease: evidence for an additional paracrine loop (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8061104%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

1 reference

R Burger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8061104%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

J Wendler

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8061104%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

K Antoni

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8061104%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

G Helm

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8061104%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

J R Kalden

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8061104%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

M Gramatzki

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8061104%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

publication date

1 July 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8061104%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8061104%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

volume

69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8061104%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8061104%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

page(s)

25-31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8061104%20AND%20SRC:MED&resulttype=core&format=json

Increased spontaneous secretion of IL-6 from B cells of patients with B chronic lymphatic leukaemia (B-CLL) and autoimmunity

24 October 2019

cites work

1 reference

12 December 2020

Interleukin-HP1, a T cell-derived hybridoma growth factor that supports the in vitro growth of murine plasmacytomas

1 reference

12 December 2020

Effect of glucocorticoids on the biologic activities of myeloma cells: inhibition of interleukin-1 beta osteoclast activating factor-induced bone resorption

1 reference

12 December 2020

Expression of interleukin-1 alpha, interleukin-1 beta and interleukin-6 in chronic B lymphocytic leukaemia (B-CLL) cells from patients at different stages of disease progression

1 reference

12 December 2020

Interleukin-6 gene expression in Castleman's disease

1 reference

12 December 2020

Glucocorticoids downregulate gene expression of GM-CSF, NAP-1/IL-8, and IL-6, but not of M-CSF in human fibroblasts

1 reference

12 December 2020

In vivo effects of recombinant human interleukin-6 in primates: stimulated production of platelets

1 reference

12 December 2020

Autocrine growth factors and tumourigenic transformation

1 reference

12 December 2020

Regulation of interleukin-6 expression in cultured human blood monocytes and monocyte-derived macrophages

1 reference

12 December 2020

Castleman's Disease and Interleukin 6.

1 reference

12 December 2020

Interleukin-1 beta rather than lymphotoxin as the major bone resorbing activity in human multiple myeloma

1 reference

12 December 2020

Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6.

1 reference

12 December 2020

Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody

1 reference

12 December 2020

Interleukin-1 accelerates autocrine growth of myeloma cells through interleukin-6 in human myeloma

1 reference

12 December 2020

Updated Kiel classification for lymphomas

1 reference

12 December 2020

Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumor cells

1 reference

12 December 2020

The biology of interleukin-6

1 reference

12 December 2020

IgG1 plasmacytosis in interleukin 6 transgenic mice

1 reference

12 December 2020

Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies

1 reference

12 December 2020

Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia

1 reference

12 December 2020

Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor

1 reference

12 December 2020

Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease

1 reference

12 December 2020

Autocrine growth factors and cancer

1 reference

12 December 2020

Production of hybridoma growth factor by human monocytes.

1 reference

12 December 2020

'Role of bone marrow stromal cells in the growth of human multiple myeloma

1 reference

12 December 2020

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

1 reference

12 December 2020

Constitutive expression of the interleukin-6 gene in chronic lymphocytic leukemia

1 reference

12 December 2020

Biological and clinical aspects of interleukin 6.

1 reference

12 December 2020

Bacterial lipopolysaccharide (endotoxin) enhances expression and secretion of beta 2 interferon by human fibroblasts

1 reference

12 December 2020

The role of interleukin-1 and tumour necrosis factor-alpha in human multiple myeloma

1 reference

12 December 2020

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

1 reference

12 December 2020

Interleukin 6 gene expression in normal and neoplastic B cells

1 reference

12 December 2020

Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice.

1 reference

12 December 2020

Mouse plasmacytoma growth in vivo: enhancement by interleukin 6 (IL-6) and inhibition by antibodies directed against IL-6 or its receptor

1 reference

12 December 2020

Effects of interferon alpha on autocrine growth factor loops in B lymphoproliferative disorders

1 reference

12 December 2020

Monoclonal antibodies EBU-141 (CDw75) and EBU-65 allow reliable distinction between mature and pre-B-cell tumors in suspension and on tissue sections

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01757344

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8061104%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

1 reference